Corpus Intelligence IC Memo — MERCY HOSPITAL CARTHAGE 2026-04-26 14:21 UTC
IC Memo — MERCY HOSPITAL CARTHAGE
Investment Committee Memorandum | MO | 25 beds | Grade C | EBITDA uplift $4.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY HOSPITAL CARTHAGE

CCN 261338 | JASPER, MO | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MERCY HOSPITAL CARTHAGE is a 25-bed suburban community hospital in JASPER, MO with $58.4M in net patient revenue and a 7.9% operating margin. The hospital serves a payer mix of 56.0% Medicare, 1.9% Medicaid, and 42.1% commercial.

Thesis: Turnaround. Our ML models identify $4.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.9% to 15.2% (+736bps).

Net Revenue HCRIS$58.4M
Current EBITDA COMPUTED$4.6M
Operating Margin COMPUTED7.9%
Occupancy HCRIS59.8%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS31.8%
Distress Probability ML44.8%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
61
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 7.9% places it above the state median. Among 61 size-comparable peers (12-50 beds), the median margin is -9.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 61 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY HOSPITAL CARTHAGE (Target)MO25$58.4M7.9%
GOLDEN VALLEY MEMORIAL HOSPITAMO42$139.8M-4.9%
WESTERN MISSOURI MEDICAL CENTEMO45$108.5M-9.2%
MERCY HOSPITAL LEBANONMO43$94.1M15.5%
CASS REGIONAL MEDICAL CENTERMO25$89.9M5.4%
MISSOURI BAPTIST SULLIVAN HOSPMO25$73.4M2.7%
MOSAIC MEDICAL CENTER - MARYVIMO29$73.3M-40.5%
NORTHEAST REGIONAL MEDICAL CENMO40$70.6M43.6%
FULTON STATE HOSPITALMO49$68.9M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$711K+122bp9mo
Clean Claim Rate88.0%96.0%$37K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.2M
Denial Rate Reduction
$1.2M
A/R Days Reduction
$711K
Clean Claim Rate
$37K
Total EBITDA Uplift$4.3M
Current EBITDA$4.6M
+ RCM Uplift+$4.3M
Pro Forma EBITDA$8.9M
Current Margin7.9%
Pro Forma Margin15.2%
WC Released (1x)$2.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.1M$73.2M10.38x59.7%
Base (11x exit)10.0x11.0x$7.1M$82.9M11.74x63.7%
Bull Case9.0x11.0x$6.4M$99.3M15.64x73.3%
Bull (12x exit)9.0x12.0x$6.4M$110.2M17.36x77.0%
Bear Case11.0x10.0x$7.8M$49.5M6.37x44.8%
Bear (11x exit)11.0x11.0x$7.8M$56.9M7.33x49.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 56.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 61 hospitals with 12-50 beds
  • Same-state prioritization (n=62)
  • Comp margins: P25=-17.8% / P50=-9.8% / P75=-1.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.